Dr. Ian Smith, MBE

Dr. Ian Smith was awarded an MBE for services to Health Research for building a global clinical trials business called Synexus which was sold in 2016 for £178m. Dr. Smith was involved in the management buyout of Synexus in 2000 - listing Synexus on the London Stock Exchange (AIM) and managed dealings with investors, before being sold to Lyceum Capital in 2007. Dr. Smith has completed more than 1000 clinical trials in the past 20 years in a wide variety of therapy areas.